Silk Road Medical, Inc
SILK
NASDAQ
Weiss Ratings | SILK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | E | |||
Rating Factors | SILK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Very Weak | |||
Solvency Index | Excellent | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | SILK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.62 | |||
Price History | SILK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -- | |||
30-Day Total Return | -- | |||
60-Day Total Return | -- | |||
90-Day Total Return | -- | |||
Year to Date Total Return | -- | |||
1-Year Total Return | -- | |||
2-Year Total Return | -- | |||
3-Year Total Return | -- | |||
5-Year Total Return | -- | |||
52-Week High % Change | -- | |||
52-Week Low % Change | -- | |||
Price | SILK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $27.51 | |||
52-Week Low Price | $6.08 | |||
52-Week Low Price (Date) | Oct 26, 2023 | |||
52-Week High Price (Date) | Sep 16, 2024 | |||
Valuation | SILK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | -- | |||
Enterprise Value | 1.03B | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -1.44 | |||
Earnings Per Share Growth | -- | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 5.69 | |||
Price/Book (Q) | 7.22 | |||
Enterprise Value/Revenue (TTM) | -- | |||
Price | -- | |||
Enterprise Value/EBITDA (TTM) | -- | |||
Enterprise Value/EBIT | -- | |||
Market Cap Category | Small Cap | |||
Dividends and Shares | SILK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 39.62M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | SILK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 408 720 9002 | |||
Address | 1213 Innsbruck Drive Sunnyvale, CA 94089 | |||
Website | silkroadmed.com | |||
Country | United States | |||
Year Founded | 2007 | |||
Profitability | SILK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -31.43% | |||
Profit Margin | -29.53% | |||
Management Effectiveness | SILK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -14.11% | |||
Return on Equity | -- | |||
Income Statement | SILK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 191.43M | |||
Total Revenue (TTM) | 191.43M | |||
Revenue Per Share | -- | |||
Gross Profit (TTM) | 142.19M | |||
EBITDA (TTM) | -57.55M | |||
EBIT (TTM) | -60.17M | |||
Net Income (TTM) | -56.54M | |||
Net Income Avl. to Common (TTM) | -56.54M | |||
Total Revenue Growth (Q YOY) | 13.12% | |||
Earnings Growth (Q YOY) | -23.13% | |||
EPS Diluted (TTM) | -1.44 | |||
EPS Diluted Growth (Q YOY) | -20.47% | |||
Balance Sheet | SILK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 171.98M | |||
Cash Per Share (Q) | $4.34 | |||
Total Current Assets (Q) | 241.02M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 154.68M | |||
Current Ratio (Q) | 7.634 | |||
Book Value Per Share (Q) | $3.81 | |||
Total Assets (Q) | 269.81M | |||
Total Current Liabilities (Q) | 31.57M | |||
Total Debt (Q) | 84.47M | |||
Total Liabilities (Q) | 115.12M | |||
Total Common Equity (Q) | 154.68M | |||
Cash Flow | SILK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | 13.94M | |||
Cash from Financing (TTM) | 14.25M | |||
Net Change in Cash (TTM) | -5.76M | |||
Levered Free Cash Flow (TTM) | -15.35M | |||
Cash from Operations (TTM) | -33.96M | |||